These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32461644)

  • 1. Take lessons from cancer evolution to the clinic.
    Swanton C
    Nature; 2020 May; 581(7809):382-383. PubMed ID: 32461644
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.
    Zheng H; Zeltsman M; Zauderer MG; Eguchi T; Vaghjiani RG; Adusumilli PS
    Immunotherapy; 2017 Sep; 9(11):913-927. PubMed ID: 29338609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To Treat or Not to Treat: Role of Immunotherapy in Patients with Concomitant Diagnosis of Advanced-Stage Non-Small Cell Lung Cancer and Psoriasis.
    Khunger M; Calabrese C; Kontzias A; Velcheti V
    J Thorac Oncol; 2017 Sep; 12(9):e147-e149. PubMed ID: 28838717
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
    Santana-Davila R; Chow LQ
    Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
    [No Abstract]   [Full Text] [Related]  

  • 5. Selecting patients for immune checkpoint inhibition in lung cancer.
    Garon EB
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):490-2. PubMed ID: 26351808
    [No Abstract]   [Full Text] [Related]  

  • 6. Nivolumab instills hope in a hopeless situation in advanced nonsmall cell lung cancer with poor performance status.
    Chandrakanth MV; Noronha V; Joshi A; Patil V; Mahajan A; Prabhash K
    Indian J Cancer; 2017; 54(1):55-56. PubMed ID: 29199664
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunotherapy for non-small cell lung cancer--novel approaches to improve patient outcome].
    Shepherd FA; Douillard JY; Blumenschein GR
    Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):C9-20. PubMed ID: 23601304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for Immunotherapy.
    Bustamante-Alvarez JG; Owen DH
    Thorac Surg Clin; 2020 May; 30(2):207-214. PubMed ID: 32327179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-small cell lung cancer: news from immunotherapy].
    Reinmuth N; Heigener DF; Reck M
    Dtsch Med Wochenschr; 2015 Mar; 140(5):329-33. PubMed ID: 25734674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A banner year for immunotherapy and targeted therapy.
    Carlisle JW; Ramalingam SS
    Nat Rev Clin Oncol; 2019 Feb; 16(2):79-80. PubMed ID: 30538305
    [No Abstract]   [Full Text] [Related]  

  • 11. Incorporating Immunotherapy Into the Treatment of Non-Small Cell Lung Cancer: Practical Guidance for the Clinic.
    Socinski MA
    Semin Oncol; 2015 Oct; 42 Suppl 2():S19-28. PubMed ID: 26477471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.
    Socinski MA
    Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469
    [No Abstract]   [Full Text] [Related]  

  • 13. How I treat stage IV non-small cell lung cancer in the absence of any actionable oncogenic driver.
    Socinski MA
    Clin Adv Hematol Oncol; 2017 Oct; 15(10):759-765. PubMed ID: 29040255
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials.
    Shaikh SS; Kumthekar PU; Mohindra NA
    J Neurooncol; 2019 Aug; 144(1):235-237. PubMed ID: 31240523
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer.
    Yuanying Y; Lizhi N; Feng M; Xiaohua W; Jianying Z; Fei Y; Feng J; Lihua H; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Oct; 67(2):235-40. PubMed ID: 23948179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in non-small-cell lung cancer: a bridge between research and clinical practice.
    Passiglia F; Commendatore O; Vitali M; Conca R
    Future Oncol; 2018 Jun; 14(13s):41-60. PubMed ID: 29989452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene immunotherapy for non-small cell lung cancer.
    Nemunaitis JJ
    Methods Mol Biol; 2009; 542():499-514. PubMed ID: 19565919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving Treatment Options for Lung Cancer.
    Morgensztern D; Herbst RS
    Hematol Oncol Clin North Am; 2017 Feb; 31(1):xiii-xiv. PubMed ID: 27912837
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent clinical trials of immunotherapy in non-small-cell lung cancer.
    Gkolfinopoulos S; Mountzios G
    Immunotherapy; 2019 Apr; 11(6):461-466. PubMed ID: 30860438
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advances of the Correlation between Driver Gene Status and Immunotherapy 
in Non-small Cell Lung Cancer].
    Chen J; Jiang D; Huang F
    Zhongguo Fei Ai Za Zhi; 2019 Apr; 22(4):233-238. PubMed ID: 31014442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.